Anzeige
Mehr »
Mittwoch, 25.02.2026 - Börsentäglich über 12.000 News
Winzig bewertet - und jetzt startet die heiße Phase mit Trigger-Fahrplan 2026
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiThe Boeing Company's (BA) 777-9 Flight Training Simulators Receives Qualification Certification
DiRTX Corporation (RTX) Gets Complete Approval for StormBreaker Smart Weapon
DiUnited Airlines selects GE Aerospace (GE)'s GEnx Engines for Boeing 787
DiHere's Artisan Mid Cap Fund's Updates on iRhythm (IRTC)
DiIn-line Results and Stronger Than Expected Outlook Lifted MACOM Technology Solutions Holdings, Inc. (MTSI) Higher
DiArtisan Mid Cap Fund Maintains Its Confidence in Argenx's (ARGX) VYVGART
DiDo You Believe in Coherent's (COHR) Longer-Term Growth Opportunities?
DiInsmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE
DiArtisan Mid Cap Fund Bets on MongoDB's (MDB) Atlas cloud platform
DiDo You Have Conviction in the Durability of ServiceTitan's (TTAN) Profit Cycle
Di11 Most Undervalued Penny Stocks to Buy Right Now
DiMicrosoft (MSFT) Needs a Refresh, Says Jim Cramer
DiI Would Raise CrowdStrike (CRWD)'s Numbers, Says Jim Cramer
Di12 Cheap NASDAQ Stocks To Buy in 2026
DiEquinor (EQNR), Eneco Enter Five-Year Gas Supply Agreement for Dutch Market
DiFDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review
DiGSK (GSK) Announces 75.6% Vaccine Effectiveness for Arexvy in Real-World RSV Study
DiFDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review
Di13 Best Strong Buy Dividend Stocks to Invest In
MoEvercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
MoSeparation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
MoOrganon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%
MoLake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
MoSanofi's (SNY) R&D Track Record Remains Investor Concern, Says BofA
MoHims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition